USANA HEALTH SCIENCES INC
For the period ended Jul 23, 2024. Filed Jul 23, 2024.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Jul 23, 2024 · Filed Jul 23, 2024
USNA$13.63-1.7%Stored close · as of Nov 6, 2026
Contents
EX-99.1 · (in thousands, except per share data)
(in thousands, except per share data)
| Quarter Ended | ||
|---|---|---|
| June 29,2024 | July 1,2023 | |
| Net sales | $212,869 | $238,202 |
| Cost of sales | 40,333 | 43,326 |
| Gross profit | 172,536 | 194,876 |
| Operating expenses: | ||
| Associate incentives | 90,371 | 102,380 |
| Selling, general and administrative | 64,325 | 68,096 |
| Total operating expenses | 154,696 | 170,476 |
| Earnings from operations | 17,840 | 24,400 |
| Other income (expense): | ||
| Interest income | 2,763 | 2,224 |
| Interest expense | (51) | (43) |
| Other, net | (349) | 229 |
| Other income (expense), net | 2,363 | 2,410 |
| Earnings before income taxes | 20,203 | 26,810 |
| Income taxes | 9,771 | 9,518 |
| Net earnings | $10,432 | $17,292 |
| Earnings per common share | ||
| Basic | $0.55 | $0.89 |
| Diluted | $0.54 | $0.89 |
| Weighted average common shares outstanding | ||
| Basic | 19,073 | 19,321 |
| Diluted | 19,159 | 19,427 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.